Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 249

1.

A Role for Branched-Chain Amino Acids in the Pathophysiology of Diabetes: Using Data to Guide Discovery.

Katz DH, Gerszten RE.

Clin Chem. 2018 Aug;64(8):1250-1251. doi: 10.1373/clinchem.2017.273516. Epub 2018 Mar 5. Review. No abstract available.

PMID:
29506975
2.

Phenomapping for the Identification of Hypertensive Patients with the Myocardial Substrate for Heart Failure with Preserved Ejection Fraction.

Katz DH, Deo RC, Aguilar FG, Selvaraj S, Martinez EE, Beussink-Nelson L, Kim KA, Peng J, Irvin MR, Tiwari H, Rao DC, Arnett DK, Shah SJ.

J Cardiovasc Transl Res. 2017 Jun;10(3):275-284. doi: 10.1007/s12265-017-9739-z. Epub 2017 Mar 3.

PMID:
28258421
3.

Archeological Echocardiography: Digitization and Speckle Tracking Analysis of Archival Echocardiograms in the HyperGEN Study.

Aguilar FG, Selvaraj S, Martinez EE, Katz DH, Beussink L, Kim KY, Ping J, Rasmussen-Torvik L, Goyal A, Sha J, Irvin MR, Arnett DK, Shah SJ.

Echocardiography. 2016 Mar;33(3):386-97. doi: 10.1111/echo.13095. Epub 2015 Nov 3.

4.

Association of Chronic Kidney Disease With Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.

Klein DA, Katz DH, Beussink-Nelson L, Sanchez CL, Strzelczyk TA, Shah SJ.

Am J Cardiol. 2015 Oct 1;116(7):1093-100. doi: 10.1016/j.amjcard.2015.06.038. Epub 2015 Jul 21.

5.

Phenomapping for novel classification of heart failure with preserved ejection fraction.

Shah SJ, Katz DH, Selvaraj S, Burke MA, Yancy CW, Gheorghiade M, Bonow RO, Huang CC, Deo RC.

Circulation. 2015 Jan 20;131(3):269-79. doi: 10.1161/CIRCULATIONAHA.114.010637. Epub 2014 Nov 14.

6.

Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fraction.

Katz DH, Burns JA, Aguilar FG, Beussink L, Shah SJ.

JACC Heart Fail. 2014 Dec;2(6):586-96. doi: 10.1016/j.jchf.2014.05.016. Epub 2014 Oct 1.

7.

Phenotypic spectrum of heart failure with preserved ejection fraction.

Shah SJ, Katz DH, Deo RC.

Heart Fail Clin. 2014 Jul;10(3):407-18. doi: 10.1016/j.hfc.2014.04.008. Epub 2014 May 22. Review.

8.

Addressing statin adverse effects in the clinic: the 5 Ms.

Katz DH, Intwala SS, Stone NJ.

J Cardiovasc Pharmacol Ther. 2014 Nov;19(6):533-42. doi: 10.1177/1074248414529622. Epub 2014 Apr 25. Review.

PMID:
24770611
9.

Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction.

Burke MA, Katz DH, Beussink L, Selvaraj S, Gupta DK, Fox J, Chakrabarti S, Sauer AJ, Rich JD, Freed BH, Shah SJ.

Circ Heart Fail. 2014 Mar 1;7(2):288-99. doi: 10.1161/CIRCHEARTFAILURE.113.000854. Epub 2013 Dec 23.

10.

Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study.

Katz DH, Selvaraj S, Aguilar FG, Martinez EE, Beussink L, Kim KY, Peng J, Sha J, Irvin MR, Eckfeldt JH, Turner ST, Freedman BI, Arnett DK, Shah SJ.

Circulation. 2014 Jan 7;129(1):42-50. doi: 10.1161/CIRCULATIONAHA.113.003429. Epub 2013 Sep 27.

11.

Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction.

Katz DH, Beussink L, Sauer AJ, Freed BH, Burke MA, Shah SJ.

Am J Cardiol. 2013 Oct 15;112(8):1158-64. doi: 10.1016/j.amjcard.2013.05.061. Epub 2013 Jun 28.

12.

Intermittent manifestation of pre-excitation syndrome: "this door is not open 24/7".

Ratanapo S, Srivali N, Cheungpasitporn W, Suksaranjit P, Chongnarungsin D, Katz DH.

Int J Cardiol. 2013 Oct 3;168(3):2938-40. doi: 10.1016/j.ijcard.2013.03.175. Epub 2013 May 9. No abstract available.

PMID:
23664050
13.

Isolated ventricular non-compaction: echocardiographic characteristics of spongy myocardium.

Srivali N, Ungprasert P, Ratanapo S, Cheungpasitporn W, Chongnarungsin D, Katz DH.

Int J Cardiol. 2013 Aug 10;167(3):e63-4. doi: 10.1016/j.ijcard.2013.03.120. Epub 2013 Apr 18. No abstract available.

PMID:
23602285
14.

Biventricular mural vegetations in a patient without valvular pathology.

Ahmed I, Katz DH, Crooke GA, Li M, Doddamani S, Haramati LB, Ostfeld RJ, Gordon GM, Spevack DM.

J Am Soc Echocardiogr. 2006 Jul;19(7):938.e5-7.

PMID:
16825007
15.

Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: A multicenter, randomized, placebo-controlled trial.

Sacks SL, Thisted RA, Jones TM, Barbarash RA, Mikolich DJ, Ruoff GE, Jorizzo JL, Gunnill LB, Katz DH, Khalil MH, Morrow PR, Yakatan GJ, Pope LE, Berg JE; Docosanol 10% Cream Study Group.

J Am Acad Dermatol. 2001 Aug;45(2):222-30.

PMID:
11464183
16.

The antiviral drug docosanol as a treatment for Kaposi's sarcoma lesions in HIV type 1-infected patients: a pilot clinical study.

Scolaro MJ, Gunnill LB, Pope LE, Khalil MH, Katz DH, Berg JE.

AIDS Res Hum Retroviruses. 2001 Jan 1;17(1):35-43.

PMID:
11177381
17.

Topical application of docosanol- or stearic acid-containing creams reduces severity of phenol burn wounds in mice.

Khalil MH, Marcelletti JF, Katz LR, Katz DH, Pope LE.

Contact Dermatitis. 2000 Aug;43(2):79-81.

PMID:
10945745
18.

The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process.

Pope LE, Marcelletti JF, Katz LR, Lin JY, Katz DH, Parish ML, Spear PG.

Antiviral Res. 1998 Dec;40(1-2):85-94.

PMID:
9864049
20.

n-Docosanol 10% cream in the treatment of recurrent herpes labialis: a randomised, double-blind, placebo-controlled study.

Habbema L, De Boulle K, Roders GA, Katz DH.

Acta Derm Venereol. 1996 Nov;76(6):479-81.

PMID:
8982417
21.

Anti-herpes simplex virus activity of n-docosanol correlates with intracellular metabolic conversion of the drug.

Pope LE, Marcelletti JF, Katz LR, Katz DH.

J Lipid Res. 1996 Oct;37(10):2167-78.

22.
23.

n-Docosanol inhibits in vitro replication of HIV and other retroviruses.

Marcelletti JF, Lusso P, Katz DH.

AIDS Res Hum Retroviruses. 1996 Jan 1;12(1):71-4. No abstract available.

PMID:
8825621
24.

n-docosanol: broad spectrum anti-viral activity against lipid-enveloped viruses.

Katz DH, Marcelletti JF, Pope LE, Khalil MH, Katz LR, McFadden R.

Ann N Y Acad Sci. 1994 Jun 6;724:472-88. No abstract available.

PMID:
8030975
25.
26.
27.

AIDS: primarily a viral or an autoimmune disease?

Katz DH.

AIDS Res Hum Retroviruses. 1993 May;9(5):489-93. No abstract available.

PMID:
8318273
28.

Biphasic effect of kallikrein on IgE and IgG1 syntheses by LPS/IL-4-stimulated B cells.

Matsushita S, Katz DH.

Cell Immunol. 1993 Jan;146(1):210-4.

PMID:
8425228
29.

Antigen concentration determines helper T cell subset participation in IgE antibody responses.

Marcelletti JF, Katz DH.

Cell Immunol. 1992 Sep;143(2):405-19.

PMID:
1387349
30.
31.

B cell activator. Effects on B cell expression of CD23, proliferation, and antibody secretion.

Marcelletti JF, Matsushita S, Katz DH.

J Immunol. 1992 Jun 15;148(12):3857-63.

PMID:
1318334
32.

Collagen-induced arthritis in mice. Relationship of collagen-specific and total IgE synthesis to disease.

Marcelletti JF, Ohara J, Katz DH.

J Immunol. 1991 Dec 15;147(12):4185-91.

PMID:
1753095
33.

Antiviral activity of 1-docosanol, an inhibitor of lipid-enveloped viruses including herpes simplex.

Katz DH, Marcelletti JF, Khalil MH, Pope LE, Katz LR.

Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10825-9.

34.
36.

Elicitation of antigen-induced primary and secondary murine IgE antibody responses in vitro.

Marcelletti JF, Katz DH.

Cell Immunol. 1991 Jul;135(2):471-89.

PMID:
2036679
37.

Purification of murine suppressive factor of allergy into distinct CD23-modulating and IgE-suppressive proteins.

Matsushita S, Marcelletti JF, Katz LR, Katz DH.

Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4718-22.

38.

Human rib bone marrow mononuclear cells spontaneously synthesize and secrete IgE in vitro.

MacDermott RP, Jendrisak GA, Nash GS, Schreiber S, Bertovich MJ, Nahm M, Nonaka M, Fitzgerald P, Katz DH, Marcelletti JF.

Clin Exp Immunol. 1991 Jan;83(1):163-8.

39.

Fc epsilon RII and the activation of B lymphocytes.

Richards ML, Katz DH.

Monogr Allergy. 1991;29:124-34. Review. No abstract available.

PMID:
1836532
40.

Biology and chemistry of low affinity IgE receptor (Fc epsilon RII/CD23).

Richards ML, Katz DH.

Crit Rev Immunol. 1991;11(2):65-86. Review.

PMID:
1834078
41.
42.

Comparison of laboratory test use among three urgent care clinics.

Lurvey NL, Kwan PH, Katz DH, Van Kruiningen HJ, Wachtel TJ.

R I Med J. 1990 May;73(5):215-8.

PMID:
2343236
43.
45.

The cellular lesion responsible for exaggerated IgE synthesis accompanying allergic breakthrough.

Marcelletti JF, Katz DH.

Cell Immunol. 1989 May;120(2):314-29.

PMID:
2524274
46.

The emerging importance of IgE and Fc receptors for IgE (Fc epsilon R) in the regulation of B cell activity.

Marcelletti JF, Richards ML, Katz DH.

Contrib Microbiol Immunol. 1989;11:188-205. Review. No abstract available.

PMID:
2555110
47.

Cloning of cDNA coding for low-affinity Fc receptors for IgE on human T lymphocytes.

Nonaka M, Hsu DK, Hanson CM, Aosai F, Katz DH.

Int Immunol. 1989;1(3):254-9.

PMID:
2535063
48.

IgE-antigen complexes enhance Fc epsilon R and Ia expression by murine B lymphocytes.

Richards ML, Marcelletti JF, Katz DH.

J Exp Med. 1988 Aug 1;168(2):571-87.

49.

Production of IL-1-mimicking anti-idiotypic antibodies in rabbits in response to IL-1 immunization.

Zuberi RI, Katz DH, Zanetti M.

J Autoimmun. 1988 Feb;1(1):31-46.

PMID:
3267107

Supplemental Content

Support Center